Minute Book, home
Coroner’s reportPrevention of future deaths · 2023-0159

“I enclose the bundle of evidence”

Dated 15 May 2023, from the coroner for Cornwall and the Isles of Scilly. Sent to 1 organisation or person.

A coroner wrote this report after an inquest, to warn the organisations below about a risk of further deaths.

Read the full report on judiciary.uk

How this works

The 56-day response deadline

All responses published

Replies were due by 10 Jul 2023.

Organisations that receive a report must reply to the coroner within 56 days, saying what they will do or why they will do nothing. We show whether a response is published on judiciary.uk; a reply may have been sent and not yet published.

  1. Report dated15 May 2023
  2. Deadline10 Jul 2023
  3. Published on judiciary.uk19 May 2023
  4. Today23 Oct 2026

Watch this report

We’ll email you when a response is published on judiciary.uk, or when the 56 days to reply end with none published there yet. Free, and you can stop with one click.

Next we ask your name, then send a link to confirm and create your free account. Already have an account? Sign in

Responses from each recipient

Responses from each recipient
Sent toResponse
Royal Cornwall Hospitals NHS TrustNamed in the report as “Royal Cornwall Hospital”Response publishedPublished on judiciary.uk in May 2023.

The coroner’s concerns

– I enclose the bundle of evidence. At pp A32-A54, you will find what I am told is the Trust’s Guideline Summary for Thrombosis Prevention and Anticoagulation. At p42, following elective knee replacement, it is suggested clinicians may choose any one of Aspirin for 14 days LMWH for 14 days and anti-embolism stockings Rivaroxaban once daily for 14 days As matters of fact, I am told Mrs Hancock was prescribed 14 days of aspirin and, in apparent error, one unidentified doctor also prescribed Dalteparin which was stopped after a single dose. It is of concern that the doctor cannot be identified and I have no record of the decision-making. At C32, you will find the Trust’s full guidance for drug prophylaxis following elective knee replacement which is taken from its Thrombosis Prevention and Anticoagulation Policy v9.0 dated Feb 2022. It provides: Low risk – Aspirin daily for 14 days High Risk – Rivaroxaban daily for 14 days or Dalteparin or Enoxaparin for 28 days plus stockings (until discharge.) had not seen the full guidance previously despite it having been published for over a year which, as a consultant orthopaedic surgeon, is of concern in itself. further said that Mrs Hancock was high risk yet she appears to have been given prophylaxis for a low risk patient because the summary guidelines appear not to reflect accurately the full guidance. , as I understood , said that it had been practice to prescribe aspirin to all high-risk patients since (at least) February 2022. This raises the question of whether other patients have died from a PE or DVT because of wrongly prescribed prophylaxis that have not been reported to this Office. You will need to consider the position. I have only considered the situation as it came before me, namely, for an elective knee replacement. As I understand the anticoagulation policy will have a much wider reach than that there is an obvious need to consider the implications across all the Trust’s services.

An extract. Read the full report, including the circumstances of the death, on the Courts and Tribunals Judiciary website.

Source
judiciary.uk, Prevention of Future Deaths reports, 2023-0159
Added to Minute Book
8 Oct 2026
Reuse
We show short extracts and link to the original. We don’t host the full report.

Something wrong, such as a date or who it was sent to? Report a mistake

Is this report about someone close to you? You can ask us to remove names from our pages.

Contains public sector information licensed under the Open Government Licence v3.0. Source: Courts and Tribunals Judiciary, judiciary.uk. Open Government Licence v3.0

Ask about this report

AI

Summaries and questions, with page references. Pro and above.

Sign in to use